ASTRAZENECA LP et al v. HEC PHARM CO., LTD. et al
| ASTRAZENECA UK LIMITED, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA LP and ASTRAZENECA AB |
| HEC PHARM USA and HEC PHARM CO., LTD. |
| 2:2019cv14737 |
| July 3, 2019 |
| US District Court for the District of New Jersey |
| Claire C Cecchi |
| Mark Falk |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on August 29, 2019. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 9 Notice to be terminated and withdraw from Notices of Electronic filing as to case. Attorney RAVIN R. PATEL terminated. (PATEL, RAVIN) |
Filing 8
STIPULATION AND ORDER that Defendants' time to answer, move or otherwise reply to Plaintiffs' Complaint is hereby extended through and including September 9, 2019.. Signed by Magistrate Judge Mark Falk on 7/15/2019. (ld, )
|
| Filing 7 Letter from John E. Flaherty to the Hon. Mark Falk, U.S.M.J. (Attachments: #1 Text of Proposed Order)(FLAHERTY, JOHN) |
|
Filing 6
ORDER REALLOCATING AND REASSIGNING CASE. Case Number 3:19-cv-14737. Case reallocated to Newark and reassigned to Judge Claire C. Cecchi and Magistrate Judge Mark Falk for all further proceedings. Judge Michael A. Shipp, Magistrate Judge Tonianne J. Bongiovanni no longer assigned to case. Signed by Chief Judge Freda L. Wolfson on 7/9/2019. (jjc)
|
| Text Minute Entry for proceedings held before Judge Michael A. Shipp: Pursuant to Local Patent Rule 1.5 Patent Pilot Project, case shall be reassigned to a designated patent judge. (gxh) |
| Filing 5 SUMMONS ISSUED as to HEC PHARM CO., LTD., HEC PHARM USA. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jdb) |
| Filing 4 AO120 Patent Form filed. (jdb) |
| Judge Michael A. Shipp and Magistrate Judge Tonianne J. Bongiovanni added. (jdb) |
| Filing 3 NOTICE of Appearance by RAVIN R. PATEL on behalf of ASTRAZENECA AB, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED (PATEL, RAVIN) |
| Filing 2 Corporate Disclosure Statement by ASTRAZENECA AB, ASTRAZENECA LP, ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA UK LIMITED identifying AstraZeneca PLC as Corporate Parent.. (FLAHERTY, JOHN) |
| Filing 1 COMPLAINT against HEC PHARM CO., LTD., HEC PHARM USA ( Filing and Admin fee $ 400 receipt number 0312-9792284), filed by ASTRAZENECA PHARMACEUTICALS LP, ASTRAZENECA LP, ASTRAZENECA AB, ASTRAZENECA UK LIMITED. (Attachments: #1 Exhibit A, #2 Exhibit B, #3 Exhibit C, #4 Civil Cover Sheet)(FLAHERTY, JOHN) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the New Jersey District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
